Turnstone Biologics Corp. (TSBX)
NASDAQ: TSBX · Real-Time Price · USD
0.3481
+0.0136 (4.07%)
At close: Jun 16, 2025, 4:00 PM
0.3482
+0.0001 (0.03%)
After-hours: Jun 16, 2025, 4:00 PM EDT

Turnstone Biologics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
81159--
Market Cap Growth
-84.32%-80.45%---
Enterprise Value
-13-32-47--
Last Close Price
0.330.502.54--
PS Ratio
--3.04--
PB Ratio
0.390.370.60--
P/TBV Ratio
0.410.370.60--
Debt / Equity Ratio
0.040.040.030.070.03
Debt / EBITDA Ratio
----0.07
Asset Turnover
--0.170.49-
Quick Ratio
3.013.537.932.613.05
Current Ratio
3.704.178.572.813.23
Return on Equity (ROE)
-126.03%-108.87%-65.27%-38.45%-
Return on Assets (ROA)
-63.31%-59.92%-32.34%-10.18%-
Return on Capital (ROIC)
-74.70%-68.12%-41.49%-18.28%-
Return on Capital Employed (ROCE)
----26.20%
Earnings Yield
-772.63%-616.37%-93.92%--
FCF Yield
-700.78%-588.79%-114.68%--
Buyback Yield / Dilution
-38.81%-99.23%-365.39%7.96%-
Updated Mar 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q